466 results
The Top Late-Breaking Trials: TRISCEND II, TRILUMINATE at 3 years, EuroSMR score, CLASP IID, OPERA-TAVI...
19 Nov 2023 – From PCR London Valves 2023
Discover the top late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND II: A randomised trial of transcatheter tricuspid valve replacement vs medical therapy
- Percutaneous edge-to-edge repair for tricuspid regurgitation: TRILUMINATE trial three-year outcomes
- Transcatheter mitral valve-in-valve vs. redo surgical replacement for degenerated bioprostheses
- Artificial intelligence derived risk...
Key questions in tricuspid valve intervention - How do I define treatment options according to individual patient anatomy?
19 Nov 2023 – From PCR London Valves 2023
Explore this tricuspid valve-focused session featuring analysis of four clinical cases: Ebstein anomaly, severe and torrential tricuspid regurgitations, and anterior flail-related torrential regurgitation. Gain insights into optimal treatment selection for each scenario, leveraging pre-procedural imaging for informed decision-making.
Key questions in tricuspid valve intervention - How does the role of the right heart and pulmonary vasculature influence patient selection?
19 Nov 2023 – From PCR London Valves 2023
Explore insights from an 86-year-old female patient's case with TAVR since end-2022 who presented with permanent AF, moderate MR and TR regurgitation, and learn more about right heart catheterisation for patient selection, CT and CMR in tricuspid interventions, criteria for atrial secondary TR, and more!
Key questions in tricuspid valve intervention - What can cardiologists learn from surgeons when choosing to repair or replace the tricuspid valve?
19 Nov 2023 – From PCR London Valves 2023
Watch this session to explore the latest approaches in surgical and transcatheter tricuspid valve repair and replacement. Gain insights into the influence of right ventricular dysfunction and pulmonary hypertension on post-procedural outcomes, and understand the bleeding risks linked to oral anticoagulation in patients with tricuspid valve...
New techniques for commissural alignment
19 Nov 2023 – From PCR London Valves 2023
Learn how to perfect your mastery of commissural alignment with the 3 cases presented in this session, which highlight new techniques: the use of coronary ostia overlap view, the octa align technique, and the RN cusp-overlap technique.
Cerebral protection devices
19 Nov 2023 – From PCR London Valves 2023
Consult the slides on this page to analyze the use of a latest-generation cerebral protection device, observe a transcatheter mitral valve-in-valve performed with cerebral protection in a TAVR case, or appreciate the value of cerebral protection in an anomalous aortic arch.
TRISCEND II: Transcatheter tricuspid valve replacement in patients with severe TR
27 Oct 2023
Mirvat Alasnag interviews Susheel K. Kodali about the results of the TRISCEND II trial which he presented during the TCT Congress 2023 in San Francisco.
Data from the first 150 patients revealed that transcatheter valve replacement effectively improved tricuspid regurgitation and patient symptoms with low adverse events at...
Author
Author
TRILUMINATE: Quality of life after transcatheter tricuspid-valve repair vs. medical therapy in severe TR
27 Oct 2023
Luigi Biasco interviews Suzanne V. Arnold about the results of the randomized TRILUMINATE pivotal trial which she presented during the TCT Congress 2023 in San Francisco
Author
Author
PCRonline @ TCT 2023 - Get the international perspective!
17 Oct 2023
Thanks to the contribution of our team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science to be released at TCT 2023 - check out the list here!
Is the invasive treatment of pulmonary embolism ready for prime time?
17 May 2023 – From EuroPCR 2023
In many parts of the world, pulmonary embolism is not a field traditionally reserved for cardiologists, but Catalin Toma and Andrew Sharp explain why they should be involved in its treatment.
As it is an RV failure problem that evolves from subclinical to frank shock, given that cardiologists...
